Functional mitral regurgitation (MR) is a common complication of cardiomyopathies associated with higher mortality(1-4). Its mechanisms have been related to left ventricular (LV)
enlargement and distorted shape, restricting mitral valve (MV) closure (5) (6) (7) (8) . However, LV remodeling alone fails to explain why MR severity varies among individuals with similar degrees of tethering (9) . Recent evidence showed that MV leaflets can enlarge in response to LV morphological changes (9) (10) (11) (12) , with the potential to reduce MR (10) . Experimentally, mechanical stretch can promote adaptive MV growth (11) , but little is known about the clinical implications of this phenomenon. A naturally occurring setting in which MV adaptation can be studied is in patients with chronic aortic regurgitation (AR), in whom functional MR is infrequent (13, 14) despite often severe LV dilatation (6, 8, (13) (14) (15) (16) (17) (18) (19) (20) (21) . This absence of MR challenges the concept linking functional MR solely to LV remodeling. Interestingly, necropsy data previously demonstrated MV enlargement in chronic AR (22) , but this finding has not been related to functional MR or its determinants in vivo. Whether or not this phenomenon can be seen as an adaptation counterbalancing LV dilatation to prevent MR is unknown.
We tested the hypothesis that MV enlargement occurs in chronic AR and preserves normal mitral geometry relative to the dilated LV to prevent MR. We first assessed functional MR prevalence in chronic AR by database review. We then prospectively enrolled patients for three-dimensional (3D) echocardiography to assess MV size and its relation with LV geometry and function in patients with either chronic AR, functional MR (ischemic or non-ischemic) or normal controls using recently developed capabilities for measuring MV area noninvasively (10) .
Methods
Retrospective analysis: To assess the prevalence of MR in patients with aortic regurgitation, we searched our institutional echocardiographic database for patients more than 18 years old with moderate or severe AR who had a transthoracic echocardiogram within the last 5 years.
Exclusion criteria were more than mild systolic dysfunction (LV ejection fraction < 40%), LV regional wall motion abnormality, severe aortic stenosis (valve area <1.0 cm 2 ), mitral valve organic pathology (prolapse, rheumatic disease, mitral cleft, endocarditis and extensive annular calcification), presence of aortic or mitral prosthesis and Marfan disease. In all patients having more than mild MR, the echocardiographic images were reviewed to confirm the presence of functional MR.
Prospective recruitment: From January 2011 to June 2012, we prospectively enrolled 90 subjects for 3D echocardiography: 30 consecutive patients who had at least moderate AR without any previously stated exclusion criteria, 30 patients with moderate or severe functional MR (ischemic or non-ischemic) and LV end-diastolic dimension comparable to the AR group, and 30 normal controls (age and gender comparable to AR group) with normal echocardiograms and without known cardiac disease (patients with treated hypertension and no evident LV hypertrophy were not excluded). AR severity was assessed with an integrative approach using color Doppler (vena contracta), regurgitant volume and fraction, and assessment of flow reversal in the descending aorta (23) . MR was graded as trace, mild, moderate or severe integrating color Doppler jet area and vena contracta width (23) (24) (25) . Medical records were consulted to assess the cause and known duration of AR. All patients gave informed consent prior to enrollment. The study was approved by the hospital's Institutional Review Board.
Echocardiography: All prospectively enrolled patients underwent standard transthoracic echocardiography using a Philips iE33 scanner with a 5-MHz transducer. Full volume 3D datasets were obtained from the apical window using an X3 matrix-array transducer. The analysis was performed by a single observer using QLAB 5.1 (Philips, Andover, MA) and custom software for mitral valve area and tethering geometry (Omni4D, MD Handschumacher).
The 3D datasets were analyzed separately and blinded to the presence and severity of AR and MR. 3D LV end-diastolic and end-systolic volumes were measured. LV sphericity was evaluated by the ratio of short-axis diameter / long-axis length at end-diastole and end-systole (8, 26) . Midsystolic (identified by frame count) tethering distances from papillary muscle tips to contralateral annulus (26) were measured from the 3D dataset. Mid-systolic mitral annular area was calculated as the projection of the annular trace onto its average or least-squares plane. Total mitral leaflet area was measured in diastole ( Figure 1 ) using a previously described and validated method that integrates valve area traced from the 3D dataset (10) . Closure area was defined as the closed leaflet surface between LV and left atrium in mid-systole and thus represents the minimal area that needs to be covered by the leaflets in order to occlude the mitral orifice. The ratios of total leaflet to annular area, and total leaflet area to closure area were calculated to assess the adequacy of leaflet adaptation relative to LV and annular changes. Dimensions, areas and volumes were indexed for body surface area. Mitral valve thickness was measured on the 2D echo datasets in parasternal long-axis view in a diastolic frame without rapid motion with the leaflets as perpendicular as possible to the echocardiographic beam to take advantage of its axial resolution (27) (28) (29) . As functional MR can be related to decreased closing forces in a failing ventricle (30, 31) , we also measured key parameters of LV contractility including 3D-calculated LVEF, end-systolic wall stress reflecting afterload (32, 33) , and end-systolic volume index, which is relatively preload-independent. In the absence of continuous wave Doppler in the patients without MR to provide true transmitral pressure, mitral closing forces were estimated as Force 
RESULTS

Retrospective review:
We identified a total of 816 patients with moderate or severe AR (Table   1 ). Moderate or severe functional MR was found in 46 patients (5.6%). Age (p<0.01), LV ejection fraction (p<0.01), LV end-diastolic (p<0.01) and end-systolic dimensions (p<0.01) were significant predictors of MR. In multivariate analysis, age (p<0.01), gender (p<0.01) and LV end-diastolic dimension (p=0.02) were significant. Table 2 ). The ratio of total leaflet area to systolic closure area was preserved in the AR group and identical to controls (1. 
Discussion
The results of this study show that despite an enlarged LV, increased sphericity, longer tethering distances and dilated mitral annulus, patients with chronic compensated AR have a surprisingly low incidence of functional MR. While the absence of MR is consistent with the usually slow clinical evolution of chronic compensated AR, this observation challenges the current concepts relating functional MR solely to LV remodeling. Three-dimensional reconstruction of the mitral valve showed that AR patients have a compensatory, greater than 30% increase in their mitral leaflet area, which remains proportional to the LV volume and the demands it imposes in terms of mitral systolic closure area. Interestingly, the AR group also had mildly thicker mitral leaflets, suggesting that enlargement is not due to passive stretch alone and raising the possibility of active growth of cells, matrix, or both. In contrast, patients with functional MR had a proportionally smaller valve increase despite similar LV size, sphericity index and tethering distances, suggesting possible factors that can limit or favor mitral valve growth depending on the underlying pathophysiology. The ratio of total leaflet area to the area required for leaflet closure, a strong determinant of MR(10), was also preserved in AR and reduced in functional MR. Valve area also increased more steeply with increasing LV end-diastolic volume in AR versus FMR. These results are in accordance with the necropsy data of Mautner et al. (22) that showed increased mitral valve area and mass in AR, and add the observations of relatively lesser increases in mitral valve area in functional MR, with a decreased ratio of total to closure leaflet areas. Of note, the absolute valve areas obtained in our study are greater than those reported by necropsy, which may relate to different measurement methods: in the necropsy study, the leaflets were formalin-fixed and excised 2 to 3 mm caudal to the annulus, which, spread over the entire annulus, can make a substantial difference in total area. The relative increase in area compared to controls was similar in both studies.
These results add to the growing literature suggesting that valve leaflets are able to remodel and adapt in response to LV morphological changes, rather than being only passive flaps. Interestingly, increased aortic leaflets dimensions have also been reported in patients with AR and aortic root dilation, suggesting aortic valve adaptation (34) . Insights from recent animal studies suggest that mitral valve mechanical stretch can induce valve growth(11) by reactivating embryonic development pathways, also shown with mechanical stretch of in vitro valve constructs (35) . Of note, the same in vivo study showed significant valve enlargement after only 60 days of mechanical stretch. That is consistent with our subset of patients having shorter AR evolution but the same degree of valve enlargement in the chronic state of LV dilatation. While mechanical stretch is likely involved, other potential mechanisms may also stimulate valve growth. It has been shown that LV eccentric hypertrophy in AR is the result of numerous extracellular matrix genes being modulated in the myocardium (36) , and expression of these genes is also modified in MR-induced volume overload (37) . It is possible that mitral valve tissue shares some of these molecular remodeling mechanisms present in the LV myocardium, which could promote valve enlargement in parallel with LV dilatation. Interestingly, a previous animal study of LV pressure overload was associated with not only mitral but also tricuspid valve changes, leading the authors to suggest the possibility of circulating factors inducing valve remodeling (38) .
Implication for functional MR:
We demonstrate here that the compensated chronic AR population shows adequate mitral leaflet adaptation, even with severe LV dilatation. In addition to disturbed ventricular geometry, functional MR is the result of an imbalance between closing and tethering forces (30, 31) . Importantly, a larger valve and annulus not only provide more tissue to cover the increased closure area, but also contribute to greater closing forces (proportional to area). In the multivariate analysis, the leaflet to closure area ratio was a strong predictor of functional MR, independent of LVEF, systolic wall stress and LV end-systolic volume index. Decreased LVEF, which reflects the underlying cardiac pathology but also the additional remodeling imposed by the presence of MR, was also significant. The presence of MR therefore depends on both leaflet enlargement and LV contractility. This adaptation is however inadequate in patients with functional MR (less valve enlargement despite comparable LV size), which remains common in ischemic and myopathic heart failure. It will therefore be relevant in future work to consider factors that can potentially impair leaflet growth in these patients.
Interestingly, while valve enlargement can promote mitral coaptation, other results have suggested that leaflet remodeling can potentially induce maladaptive valve stiffness and fibrosis (39) , interfering with valve function (40, 41) . This suggests that mitral leaflet remodeling could be a double-edged sword, preventing MR in certain situations, but with the potential of contributing to MR in other cases. One major difference between our chronic stable AR population and other ischemic or non-ischemic cardiomyopathies is the preserved systolic function and the absence of clinical heart failure. Heart failure is associated with strong humoral and pro-inflammatory cytokine activation, factors well known to induce and modify remodeling in the LV and numerous other organs. Although renin-angiotensin and adrenergic systems are also activated in chronic AR (42, 43) , the magnitude of this activation in asymptomatic patients with preserved function is likely lower than what is seen in the setting of ischemic and nonischemic systolic dysfunction. It is currently unknown if this exaggerated humoral activation can modify valve leaflet growth, although the pro-fibrotic effects of angiotensin are well described (44, 45) . Future mechanistic studies are warranted to explore the factors potentially limiting leaflet growth and flexible closure, as they could eventually represent future therapeutic targets.
Limitations: The observed increases in leaflet area and thickness suggest possible cellular growth activation, but no biological samples were available in this imaging study. Our study shows that compensated AR is associated with adequate mitral valve adaptation; but the biological mechanisms leading to valve growth need to be explored. We are currently planning additional studies looking at valve area over time in chronic AR, acute AR, and the transition to decompensated heart failure, where clinical experience indicates FMR is more common. Also, the influence of other variables such as age, medication and comorbidities on mitral valve adaptation and incidence of FMR in various populations (ischemic and non-ischemic heart failure) needs to be assessed in clinical studies designed to address those influences.
Conclusion: Patients with chronic, clinically stable moderate to severe aortic regurgitation have a large increase in mitral leaflet size. This increase is proportional to the LV enlargement and, in addition to preserved contractility, can represent an adaptative mechanism to prevent mitral regurgitation in a dilated ventricle. Further mechanistic studies are needed to explore how we can modulate this adaptation to prevent functional MR in other diseases.
Figures legends: Figure 1 : Mitral valve reconstruction for total leaflet area measurement using threedimensional echocardiography. Sequential leaflet tracing in multiple planes allows computation of total mitral leaflet area (measurable clearly only in diastole, because the systolic areas of leaflet coaptation cannot be uniformly visualized (10)). 
